Modified Bacteria Show Promise Against Drug-Resistant Biofilms

Scientists have developed a novel "living medicine" that effectively thinned biofilms of antibiotic-resistant *Pseudomonas aeruginosa* in pig lungs. This experimental treatment, utilizing modified bacteria, represents a significant advancement in combating drug-resistant infections. It particularly addresses critical issues like those associated with medical implants and ventilator-associated pneumonia in hospital settings.